Cargando…
Targeting CYP2J2 to Enhance the Anti-Glioma Efficacy of Cannabinoid Receptor 2 Stimulation by Inhibiting the Pro-Angiogenesis Function of M2 Microglia
Enhancing the therapeutic efficacy of anti-tumor drugs is essential for cancer management. Although cannabinoid receptor 2 (CB2R) stimulation exerts anti-tumor action in glioma cells by regulating cellular proliferation, differentiation, or apoptosis, selective CB2R agonist alone does not achieve a...
Autores principales: | Lei, Xuejiao, Chen, Xuezhu, Quan, Yulian, Tao, Yihao, Li, Junlong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729163/ https://www.ncbi.nlm.nih.gov/pubmed/33330047 http://dx.doi.org/10.3389/fonc.2020.574277 |
Ejemplares similares
-
The development of novel cytochrome P450 2J2 (CYP2J2) inhibitor and the underlying interaction between inhibitor and CYP2J2
por: Tian, Xiangge, et al.
Publicado: (2021) -
Interactions between microglia and glioma in tumor microenvironment
por: Tao, Jin-Cheng, et al.
Publicado: (2023) -
ROS-responsive nanoparticle-mediated delivery of CYP2J2 gene for therapeutic angiogenesis in severe hindlimb ischemia
por: Gui, Liang, et al.
Publicado: (2021) -
The pro-invasive factor COL6A2 serves as a novel prognostic marker of glioma
por: Zhu, Jinchao, et al.
Publicado: (2022) -
Opposite Effects of Neuroprotective Cannabinoids, Palmitoylethanolamide, and 2-Arachidonoylglycerol on Function and Morphology of Microglia
por: Hohmann, Urszula, et al.
Publicado: (2019)